Publication Date:
2015
abstract:
Basic bulky amines such as amantadine are well-characterized M2 channel blockers, useful for treating influenza. Herein we report our surprising findings that charge-neutral, bulky isocyanides exhibit activities similar to - or even higher than - that of amantadine. We also demonstrate that these isocyanides have potent growth inhibitory activity against the H5N1 virus. The -NH2 to -N?C group replacement within current anti-influenza drugs was found to give compounds with high activities at low-micromolar concentrations. For example, a tenfold improvement in potency was observed for 1-isocyanoadamantane (27), with an EC50 value of 0.487 ?m against amantadine-sensitive H5N1 virus as determined by both MTT and plaque-reduction assays, without showing cytotoxicity. Furthermore, the isocyanide analogues synthesized in this study did not inhibit the V27A or S31N mutant M2 ion channels, according to electrophysiology experiments, and did not exhibit activity against amantadine-resistant virus strains. Charge-neutral bulky isocyanides were found to exhibit antiviral activities similar to - or even higher than - that of amantadine. Moreover, we demonstrated that these isocyanides have potent growth inhibitory activity against the wild-type H5N1 virus. The NH2 to N?C group replacement within current anti-influenza drugs was found to result in compounds with low-micromolar activities. © 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Iris type:
01.01 Articolo in rivista
Keywords:
1 (1 isocyanoethyl)adamantine; 1 (tert butyl) 4 isocyanocyclohexane; 1 isocyanoadamantane; 2 isocyano 2; 4; 4 trimethylpentane; 2 isocyanoadamantane; 3 isocyano 2; 6; 6 trimethylbicyclo[3.1.1; 3 isocyanoadamantan 1 ol; 5 (tert butyl) 2 isocyano 1; 3 dimethylbenzene; amantadine; antivirus agent; isocyanide; n ( 2; 6; 6 trimethylbicyclo[3.1.1]heptan 3 yl)formamide; n (adamantan 1 yl)formamide; n [4 (tert butyl)cyclohexyl]formamide; unclassified drug; antivirus agent; cyanide; M2 protein; Influenza A virus; matrix protein; animal experiment; antiviral activity; Article; carbon nuclear magnetic resonance; controlled study; drug binding site; drug clearance; drug synthesis; EC50; IC50; influenza A; Influenza A virus (H1N1); Influenza A virus (H5N1); Influenza virus; MDCK cell line; molecular docking; molecular dynamics; mouse; nonhuman; priority journal; proton nuclear magnetic resonance; site directed mutagenesis; structure activity relation; virus attachment; virus inhibition; virus strain; animal; antagonists and inhibitors; chemistry; dog; dose response; drug effects; growth; development and aging; Influenza A virus (H5N1); metabolism; microbial sensitivity test; microbiology; synthesis; Animals; Antiviral Agents; Cyanides; Dogs; Dose-Response Relationship; Drug; Influenza A Virus; H5N1 Subtype; Madin Darby Canine Kidney Cells; Microbial Sensitivity Tests; Structure-Activity Relationship; Viral Matrix Proteins
List of contributors:
Moroni, Anna
Published in: